Alps Advisors Inc Atossa Therapeutics, Inc. Transaction History

Alps Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.85 - $1.28 $110,619 - $166,580	-130,141 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.11 - $1.74 $18,205 - $28,537	-16,401 Reduced 11.19%	130,141 $163,000
Q4 2021 Feb 09, 2022	BUY	$1.6 - $3.27 $234,467 - $479,192	146,542 New	146,542 $234,000

19.3M

95K

82.4K

Ticker ATOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,624,000
Market Cap $147M
Description
Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing A...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.